BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2442510)

  • 1. Discussion on the natriuretic effect of calcium antagonists.
    Zanchetti A; Leonetti G
    J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S161-4. PubMed ID: 2442510
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the renal effects of calcium antagonists.
    Ruilope LM; Lahera V; Rodicio JL
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S49-53. PubMed ID: 7609506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-channel-blocking drugs and renal sodium excretion.
    Luft FC
    Am J Nephrol; 1987; 7 Suppl 1():39-43. PubMed ID: 3327380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kidney and strategies for the treatment of hypertension.
    Hollenberg NK
    Am J Med; 1984 Oct; 77(4A):60-3. PubMed ID: 6207726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can calcium channel blockers preserve renal function better than diuretics during antihypertensive treatment?
    Fukuda M; Kimura G
    Arch Intern Med; 2005 Jun; 165(11):1312; author reply 1312-3. PubMed ID: 15956015
    [No Abstract]   [Full Text] [Related]  

  • 6. Natriuretic effect of calcium antagonists.
    Zanchetti A; Leonetti G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S33-7. PubMed ID: 2412009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists and the kidney.
    Epstein M
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S18-24. PubMed ID: 7603073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic effects of calcium antagonists. Clinical implications.
    Zanchetti A; Leonetti G
    Drugs; 1990; 40 Suppl 2():15-21. PubMed ID: 2150634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies in antihypertensive therapy: implications of the kidney.
    Hollenberg NK
    Am J Med; 1986 Dec; 81(6A):15-9. PubMed ID: 2879443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of calcium antagonists on electrolytes and water balance in hypertensive patients.
    Leonetti G
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S25-9. PubMed ID: 7603074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of the natriuretic effect of calcium entry blockers.
    Ruilope LM; Miranda B; Oliet A; Alcazar JM; Bigorra J; Rodicio JL
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S136-9. PubMed ID: 2468857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors involved in the antihypertensive action of calcium antagonists.
    Garthoff B; Kazda S; Knorr A; Thomas G
    Hypertension; 1983; 5(4 Pt 2):II34-8. PubMed ID: 6345375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic sodium handling and the natriuretic action of calcium antagonists.
    Zanchetti A; Stella A; Golin R
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S194-8. PubMed ID: 2414587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive and renal effects of nicardipine.
    van Schaik BA; van Nistelrooy AE; Geyskes GG
    Br J Clin Pharmacol; 1984 Jul; 18(1):57-63. PubMed ID: 6743490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension, nephrosclerosis and calcium antagonists].
    del Río A
    Med Clin (Barc); 1989 Jan; 92(3):98-101. PubMed ID: 2709903
    [No Abstract]   [Full Text] [Related]  

  • 16. Natriuretic effect of barnidipine, a long-acting dihydropyridine calcium channel blocker, in patients with essential hypertension.
    Ohya Y; Abe I; Ohta Y; Onaka U; Fujii K; Kagiyama S; Fujishima-Nakao Y; Fujishima M
    Int J Clin Pharmacol Ther; 2000 Jun; 38(6):304-8. PubMed ID: 10890579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
    Cerasola G; Cottone S; Mangano MT; D'Ignoto G; Pinto A; Carone MB
    Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic effects of calcium channel blockers.
    Toyoda S; Sakuma M; Node K; Inoue T
    Hypertens Res; 2018 Apr; 41(4):230-233. PubMed ID: 29449704
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium antagonists and the kidney.
    Pearce CJ; Wallin JD
    New Horiz; 1996 Feb; 4(1):123-8. PubMed ID: 8689267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin A1: antihypertensive and renal effects. Studies in patients with essential hypertension.
    Lee JB; McGiff JC; Kannegiesser H; Aykent YY; Mudd JG; Frawley TF
    Ann Intern Med; 1971 May; 74(5):703-10. PubMed ID: 5559434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.